Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

(2021) Marius M Hoeper et al.   Lancet Respiratory Medicine

Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE

(2020) Raymond L. Benza et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

(2019) Marc Humbert et al.   EUROPEAN RESPIRATORY JOURNAL

Predicting Survival in Patients with Pulmonary Arterial Hypertension

(2019) Raymond L. Benza et al.   CHEST

REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival

(2018) Raymond L. Benza et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat

(2018) Raymond L. Benza et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension

(2018) Roberto Badagliacca et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Tolerability and clinical efficacy of inhaled treprostinil in patients with group 1 pulmonary arterial hypertension

(2018) Cher Y. Enderby et al.   Therapeutic Advances in Chronic Disease

An overview of the 6th World Symposium on Pulmonary Hypertension

(2018) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Risk stratification and medical therapy of pulmonary arterial hypertension

(2018) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Clinical trial design and new therapies for pulmonary arterial hypertension

(2018) Olivier Sitbon et al.   EUROPEAN RESPIRATORY JOURNAL

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients

(2018) Marion Delcroix et al.   EUROPEAN RESPIRATORY JOURNAL

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

(2017) Marius M. Hoeper et al.   EUROPEAN RESPIRATORY JOURNAL

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

(2017) Athénaïs Boucly et al.   EUROPEAN RESPIRATORY JOURNAL

How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension

(2017) Rebecca R. Vanderpool et al.   EUROPEAN RESPIRATORY JOURNAL

Effects of long-term iloprost treatment on right ventricular function in patients with Eisenmenger syndrome

(2017) Min Ku Chon et al.   Journal of Cardiology

Comparison of hemodynamic parameters in treatment-naïve and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 study

(2017) Nazzareno Galiè et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups

(2017) Henning Gall et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension

(2017) Jason Weatherald et al.   CIRCULATION

A comparison of echocardiographic variables of right ventricular function with exercise capacity after bosentan treatment in patients with pulmonary arterial hypertension: Results from a multicenter, prospective, cohort study

(2016) Hyungseop Kim et al.   JOURNAL OF CLINICAL ULTRASOUND

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial

(2016) Hossein-Ardeschir Ghofrani et al.   Lancet Respiratory Medicine

Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial

(2016) Gérald Simonneau et al.   Lancet Respiratory Medicine

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)

(2015) Lewis J. Rubin et al.   EUROPEAN RESPIRATORY JOURNAL

Exercise pathophysiology and sildenafil effects in chronic thromboembolic pulmonary hypertension

(2015) Guido Claessen et al.   HEART

Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis

(2015) Raymond L. Benza et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)

(2014) Gérald Simonneau et al.   EUROPEAN RESPIRATORY JOURNAL

Effects of Inhaled Iloprost on Exercise Capacity, Quality of Life, and Cardiac Function in Patients With Pulmonary Arterial Hypertension Secondary to Congenital Heart Disease (the Eisenmenger Syndrome) (from the EIGER Study)

(2013) Kwang Soo Cha et al.   AMERICAN JOURNAL OF CARDIOLOGY

Methods for Measuring Right Ventricular Function and Hemodynamic Coupling with the Pulmonary Vasculature

(2013) Alessandro Bellofiore et al.   ANNALS OF BIOMEDICAL ENGINEERING

Anticoagulation and Survival in Pulmonary Arterial Hypertension

(2013) Karen M. Olsson et al.   CIRCULATION

Bosentan Treatment Is Associated With Improvement of Right Ventricular Function and Remodeling in Chronic Thromboembolic Pulmonary Hypertension

(2013) Sulaiman Surie et al.   CLINICAL CARDIOLOGY

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Riociguat for the Treatment of Pulmonary Arterial Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Effect of Bosentan Therapy on Cardiac Function and Symptomatic Benefits in Adult Patients With Eisenmenger Syndrome

(2012) Mehmet G. Kaya et al.   JOURNAL OF CARDIAC FAILURE

The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

(2011) Raymond L. Benza et al.   CHEST

Predicting Survival in Pulmonary Arterial Hypertension

(2010) Raymond L. Benza et al.   CIRCULATION